The use of methylphenidate and other psychotropic drugs to treat preschool-aged children with attention-deficit/hyperactivity disorder (ADHD) has long been controversial because few data previously had been available to support the practice. Now a growing body of preliminary evidence indicates that these very young children can benefit from such treatment but that adverse events in this age group require special consideration.
Other studies are probing the potential long-term consequences of treatment and exploring the role of genetics in the disorder.
Kuehn BM. Scientists Examine Benefits, Risks of Treating Preschoolers With ADHD Drugs. JAMA. 2007;298(15):1747–1749. doi:10.1001/jama.298.15.1747
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: